MARKET RADAR
SENSEX     NIFTY      Refresh
Natco Pharma Yearly Results, Natco Pharma Financial Statement & Accounts
YOU ARE HERE > MONEYCONTROL > MARKETS > Pharmaceuticals > Yearly Results - Natco Pharma
Natco Pharma
BSE: 524816|NSE: NATCOPHARM|ISIN: INE987B01018|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
May 22, 17:00
434.75
2.55 (0.59%)
VOLUME 3,172
LIVE
NSE
May 22, 17:00
435.30
1.8 (0.42%)
VOLUME 17,270
Download Annual Report PDF Format 2012 | 2011 | 2010

Yearly Results of Natco Pharma

------------------- in Rs. Cr. -------------------
Mar '12 Mar '11 Mar '10 Mar '09 Mar '08
Net Sales/Income from operations 430.42 371.74 291.24 286.07 227.88
Other Operating Income 37.21 -- -- -- --
Total Income From Operations 467.63 371.74 -- -- --
EXPENDITURE
Consumption of Raw Materials 117.68 97.42 80.94 86.71 76.20
Purchase of Traded Goods 15.53 16.72 -- -- --
Increase/Decrease in Stocks 0.75 -11.48 3.35 -7.10 -4.05
Power & Fuel -- -- -- -- --
Employees Cost 64.87 51.12 42.17 35.65 29.23
Depreciation 15.41 14.35 12.45 10.35 8.59
Excise Duty -- -- -- -- --
Admin. And Selling Expenses -- -- -- -- --
R & D Expenses -- -- -- -- --
Provisions And Contingencies -- -- -- -- --
Exp. Capitalised -- -- -- -- --
Other Expenses 151.19 126.16 111.27 97.45 86.81
P/L Before Other Inc. , Int., Excpt. Items & Tax 102.20 77.45 -- -- --
Other Income 3.27 0.72 36.69 -- 22.75
P/L Before Int., Excpt. Items & Tax 105.47 78.17 -- -- --
Interest 22.96 14.19 14.69 13.73 8.50
P/L Before Exceptional Items & Tax 82.51 63.98 63.06 49.28 --
Exceptional Items -- -- -- -- --
P/L Before Tax 82.51 63.98 -- -- --
Tax 20.38 11.86 13.20 10.68 14.50
P/L After Tax from Ordinary Activities 62.13 52.12 -- -- --
Prior Year Adjustments -- -- -- -- --
Extra Ordinary Items -- -- -2.20 4.14 9.20
Net Profit/(Loss) For the Period 62.13 52.12 47.66 42.74 40.05
Equity Share Capital 31.15 28.15 28.15 28.04 28.04
Reserves Excluding Revaluation Reserves 436.32 318.76 273.28 229.86 --
Equity Dividend Rate (%) -- -- -- -- --
EPS Before Extra Ordinary
Basic EPS 21.39 18.52 -- -- --
Diluted EPS 21.39 18.52 -- -- --
EPS After Extra Ordinary
Basic EPS 21.39 18.52 -- -- --
Diluted EPS 21.39 18.52 -- -- --
Public Share Holding
No Of Shares (Crores) 1.34 1.05 1.05 1.08 1.11
Share Holding (%) 42.95 37.16 37.41 38.46 39.71
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of shares (Crores) -- 0.11 -- -- --
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- 5.94 -- -- --
- Per. of shares (as a % of the total Share Cap. of the company) -- 3.73 -- -- --
b) Non-encumbered
- Number of shares (Crores) 1.78 1.66 -- -- --
- Per. of shares (as a % of the total sh. of prom. and promoter group) 100.00 94.06 -- -- --
- Per. of shares (as a % of the total Share Cap. of the company) 57.05 59.11 -- -- --
Notes Notes To The Accounts Notes To The Accounts Notes To The Accounts
Source : Dion Global Solutions Limited

Results of Natco Pharma

Quick Links for natcopharma
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.